WO2023057871 - SURFACTANT STABILIZERS
National phase entry:
Publication Number
WO/2023/057871
Publication Date
13.04.2023
International Application No.
PCT/IB2022/059404
International Filing Date
03.10.2022
Title **
[English]
SURFACTANT STABILIZERS
[French]
STABILISANTS TENSIOACTIFS
Applicants **
NOVARTIS AG
Lichtstrasse 35
4056 Basel, CH
Inventors
BECHTOLD-PETERS, Karoline
Novartis Pharma AG, Postfach
4002 Basel, CH
BROSIG, Sebastian
Novartis Pharma AG, Postfach
4002 Basel, CH
GALLOU, Fabrice
Novartis Pharma AG, Postfach
4002 Basel, CH
PARMENTIER, Michael
Novartis Pharma AG, Postfach
4002 Basel, CH
SERNO, Tim
Novartis Pharma AG, Postfach
4002 Basel, CH
THAKARE, Vivek Sudam
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl, AT
Priority Data
21200819.7
04.10.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1618 | |
| EPO | Filing, Examination | 6819 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 4510 |
Total: 14113 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention is directed to stabilized protein-containing formulations, stabilized or inhibited against protein aggregation, comprising an amphiphilic surfactant.[French]
La présente invention concerne des formulations contenant des protéines stabilisées, stabilisées ou inhibées contre l'agrégation de protéines, comprenant un tensioactif amphiphile.